Quick Search:       Advanced Search
Research progress on trained immunity in tumor multimodality therapy
Received:August 25, 2023  Revised:September 14, 2023  Click here to download the full text
Citation of this paper:BU Yi-chao,FU Xiu-tao,DING Zhen-bin,LIU Wei-ren,SHI Ying-hong,FAN Jia,TANG Zheng.Research progress on trained immunity in tumor multimodality therapy[J].Chinese Journal of Clinical Medicine,2023,30(5):861-869
Hits: 603
Download times: 160
Author NameAffiliationE-mail
BU Yi-chao Department of Liver Surgery, Zhongshan Hospital, Fudan University, Liver Cancer Institute, Fudan University, Shanghai 200032, China  
FU Xiu-tao Department of Liver Surgery, Zhongshan Hospital, Fudan University, Liver Cancer Institute, Fudan University, Shanghai 200032, China  
DING Zhen-bin Department of Liver Surgery, Zhongshan Hospital, Fudan University, Liver Cancer Institute, Fudan University, Shanghai 200032, China  
LIU Wei-ren Department of Liver Surgery, Zhongshan Hospital, Fudan University, Liver Cancer Institute, Fudan University, Shanghai 200032, China  
SHI Ying-hong Department of Liver Surgery, Zhongshan Hospital, Fudan University, Liver Cancer Institute, Fudan University, Shanghai 200032, China  
FAN Jia Department of Liver Surgery, Zhongshan Hospital, Fudan University, Liver Cancer Institute, Fudan University, Shanghai 200032, China  
TANG Zheng Department of Liver Surgery, Zhongshan Hospital, Fudan University, Liver Cancer Institute, Fudan University, Shanghai 200032, China tang.zheng@zs-hospital.sh.cn 
Abstract:The classical immune system is divided into innate immunity and acquired immunity. The general view is that immune memory exists only in acquired immunity. However, in organisms lacking adaptive immunity, cells of the innate immune system are able to acquire memory signatures after a brief stimulus, thereby enhancing the response upon a secondary stimulus, a phenomenon known as training immunity. Trained immunity can play a unique anti-tumor role in tumors. In bladder cancer, training immunity induced by BCG vaccine has become the standard treatment for bladder cancer. The efficacy of BCG in the treatment of melanoma has also been recognized in recent years. Improving immune training during therapy through irreversible electroporation (IRE) can prolong survival in patients with pancreatic cancer. Whole β-glucan particle (WGP) can inhibit tumor lung metastasis. In breast cancer, the introduction of drugs through nanoparticles (NPs) can improve the training immune effect of targeted sites. This paper reviews the concepts, mechanisms, and current status of training immunity in the field of oncology therapy.
keywords:trained immunity  innate immune memory  immune microenvironment  tumor therapy
HTML  View Full Text  View/Add Comment  Download reader